The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study
Articolo
Data di Pubblicazione:
2004
Abstract:
One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisfactory results. We performed a prospective randomised study with the aim of either evaluating whether the triple therapy prolongation may improve its effectiveness and comparing its outcome with that of sequential regimen.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship; Drug; Drug Administration Schedule; Drug Therapy; Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Smoking; Tinidazole; Treatment Outcome
Elenco autori:
De Francesco, V; Zullo, A; Hassan, Cesare; Della Valle, N; Pietrini, L; Minenna, Mf; Winn, S; Monno, R; Stoppino, V; Morini, S; Panella, C; Ierardi, E.
Link alla scheda completa:
Pubblicato in: